{"id":2985,"date":"2024-01-19T19:27:26","date_gmt":"2024-01-19T10:27:26","guid":{"rendered":"https:\/\/www.pharm.kyoto-u.ac.jp\/byotai\/?page_id=2985"},"modified":"2024-12-02T12:45:54","modified_gmt":"2024-12-02T03:45:54","slug":"2019-2","status":"publish","type":"page","link":"https:\/\/www.pharm.kyoto-u.ac.jp\/byotai\/2019-2\/","title":{"rendered":"2019"},"content":{"rendered":"

2019 (\u8ad6\u6587)<\/h2>\n
    \n
  1. Watanabe H, Matsushita N, Shimizu Y, Iikuni S, Nakamoto Y, Togashi K, Ono M.
    \n<\/span><\/span><\/span><\/span><\/span>Synthesis and characterization of a novel 18<\/sup>F-labeled 2,5-diarylnicotinamide derivative targeting orexin 2 receptor<\/span><\/span><\/span><\/span><\/span>
    \nMed. Chem. Commun. <\/span><\/span><\/em>10(12) 2126-2130 (2019)<\/span><\/span><\/li>\n
  2. Watanabe H, Itagaki F, Shimizu Y, Iikuni S, Ono M.
    \n<\/span><\/span><\/span><\/span><\/span>Synthesis and evaluation of a radioiodinated BODIPY derivative as a thiol labeling agent<\/span><\/span><\/span><\/span><\/span>
    \nJ. Labelled Comp. Radiopharm. <\/span><\/span><\/em>62(13) 885-891 (2019)<\/span><\/span><\/li>\n
  3. Yagi Y, Kimura H, Okuda H, Ono M, Nakamoto Y, Togashi K, Saji H.
    \n<\/span><\/span><\/span><\/span><\/span>Evaluation of [18<\/sup>F]pitavastatin as a positron emission tomography tracer for in vivo organic transporter polypeptide function<\/span><\/span><\/span><\/span><\/span>
    \nNucl. Med. Biol. <\/span><\/span><\/em>74-75<\/span><\/span>\u00a025-31 (2019)<\/span><\/span><\/li>\n
  4. Mori D, Kimura H, Kawashima H, Yagi Y, Arimitsu K, Ono M, Saji H.<\/span>
    \n<\/span><\/span><\/span><\/span>Development of 99m<\/sup>Tc Radiolabeled A85380 Derivatives Targeting Cerebral Nicotinic Acetylcholine Receptor: Novel Radiopharmaceutical Ligand 99m<\/sup>Tc-A-YN-IDA-C4<\/span><\/span><\/span><\/span><\/span>
    \nBioorg. Med. Chem. <\/span><\/span><\/em>27(18) 4200-4210 (2019)<\/span><\/span><\/li>\n
  5. Kaide S, Watanabe H, Shimizu Y, Tatsumi H, Iikuni S, Nakamoto Y, Togashi K, Ihara M, Saji H, Ono M.<\/span><\/span><\/span><\/span>
    \n18<\/span><\/sup>F-Labeled Benzimidazopyridine Derivatives for PET Imaging of Tau Pathology in Alzheimer\u2019s Disease<\/span><\/span><\/span><\/span>
    \nBioorg. Med. Chem. <\/span><\/span><\/em>27(16) 3587-3594 (2019)<\/span><\/span><\/li>\n
  6. Shimizu Y, Tanimura K, Iikuni S, Watanabe H, Saji H, Ono M.
    \n<\/span><\/span><\/span><\/span>Development of technetium-99m-labeled BODIPY-based probes targeting lipid droplets for diagnosis of hyperlipidemia-related diseases<\/span><\/span><\/span><\/span>
    \nMolecules<\/em>\u00a024(12) 2283 (2019)<\/span><\/span><\/li>\n
  7. Watanabe H, Miki Y, Shimizu Y, Saji H, Ono M.<\/span><\/span><\/span><\/span>
    \n<\/span><\/span><\/span>Synthesis and evaluation of novel two-photon fluorescence probes for in vivo imaging of amylin aggregates in the pancreas<\/span><\/span><\/span><\/span>
    \nDyes. Pigm. <\/span><\/span><\/em>170 107615 (2019)<\/span><\/span><\/span><\/li>\n
  8. Kimura H, Yagi Y, Mikamo M, Maeda K, Kagawa S, Arimitsu K, Higashi T, Nishii R, Ono M, Nakamoto Y, Togashi K, Kusuhara H, Saji H.<\/span><\/span><\/span><\/span>
    \n<\/span><\/span><\/span>Evaluation of Transporter-Mediated Hepatobiliary Transport of Newly Developed 18<\/sup>F-labeled Pitavastatin Derivative, PTV-F1, in Rats by PET Imaging<\/span><\/span><\/span><\/span>
    \nDrug Metab. Pharmacokinet.<\/em>\u00a034(5) 317-324 (2019)<\/li>\n
  9. Watanabe H, Fukui K, Shimizu Y, Idoko Y, Nakamoto Y, Togashi K, Saji H, Ono M.<\/span><\/span><\/span><\/span>
    \n<\/span><\/span><\/span>Synthesis and biological evaluation of F-18 labeled tetrahydroisoquinoline derivatives targeting orexin 1 receptor<\/span><\/span><\/span><\/span>
    \nBioorg. Med. Chem. Lett.<\/em> 29(13) 1620-1623 (2019)<\/span><\/li>\n
  10. Fuchigami T, Kawasaki M, Koyama R, Nakaie M, Nakagaki T, Sano K, Atarashi R, Yoshida S, Haratake M, Ono M, Nishida N, Nakayama M.<\/span><\/span><\/span><\/span>
    \n<\/span><\/span><\/span>Development of radioiodinated benzofuran derivatives for in vivo imaging of prion deposits in the brain<\/span><\/span><\/span><\/span>
    \nACS Infect. Dis. <\/i>5(12) 2003-2013 (2019)<\/li>\n
  11. Iikuni S, Tanimura K, Watanabe H, Shimizu Y, Saji H, Ono M.<\/span><\/span><\/span><\/span>
    \n<\/span><\/span><\/span>Development of 99m<\/sup>Tc-Hydroxamamide Complex as Probe Targeting Carbonic Anhydrase IX<\/span><\/span><\/span><\/span>
    \nMol. Pharm. <\/em>16(4) 1489-1497 (2019)<\/li>\n
  12. Yamauchi H, Kagawa S, Takahashi M, Oishi N, Ono M, Higashi T.<\/span><\/span><\/span><\/span>
    \n<\/span><\/span><\/span>Misery perfusion and amyloid deposition in atherosclerotic major cerebral artery disease<\/span><\/span><\/span><\/span>
    \nNeuroimage: Clinical<\/em>\u00a022 101762<\/span> (2019)<\/li>\n
  13. Saga T, Nakamoto Y, Ishimori T, Inoue T, Shimizu Y, Kimura H, Akamatsu S, Goto T, Watanabe H, Kitaguchi K, Watanabe M, Ono M, Saji H, Ogawa O, Togashi K.<\/span><\/span><\/span><\/span>
    \n<\/span><\/span><\/span>Initial evaluation of PET\/CT with 18<\/sup>F-FSU-880 targeting prostate-specific membrane antigen in prostate cancer patients<\/span><\/span><\/span><\/span>
    \nCancer Sci. <\/span><\/em>110(2) 742-750<\/span>\u00a0(2019)<\/li>\n<\/ol>\n

    \u30da\u30fc\u30b8\u306e\u5148\u982d\u3078\u623b\u308b<\/a><\/p>\n

    2019 (\u8457\u66f8\u7b49)<\/h2>\n
      \n
    1. \u6e21\u908a \u88d5\u4e4b\uff0c\u5c0f\u91ce \u6b63\u535a.<\/span>
      \n<\/span><\/span><\/span><\/span>\u30bf\u30a6\u306ePET\u30a4\u30e1\u30fc\u30b8\u30f3\u30b0<\/span><\/span><\/span><\/span><\/span>
      \n\u8133\u795e\u7d4c\u5185\u79d1 91(1) 48-53 (2019)<\/li>\n<\/ol>\n

      \u30da\u30fc\u30b8\u306e\u5148\u982d\u3078\u623b\u308b<\/a><\/p>\n

      2019 (\u5b66\u4f1a\u767a\u8868)<\/h2>\n
        \n
      1. Masahiro Ono<\/span><\/span><\/span><\/span><\/span>
        \nDevelopment of PET\/SPECT Tracers for \u03b2-Amyloid and Tau Imaging\u00a0<\/span>(Invited Lecture)<\/span>
        \n<\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span>International Workshop on Brain Imaging for Neural Activity\u00a0<\/span>(Hamamatsu, Japan) July\u00a03, 2019<\/span><\/span><\/span><\/li>\n
      2. Shimpei Iikuni, Hiroyuki Watanabe, Yoichi Shimizu, Masahiro Ono<\/span><\/span><\/span><\/span><\/span><\/span>
        \nDevelopment of radiogallium complex for imaging of carbonic anhydrase-IX overexpressed in hypoxic regions of solid tumors<\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span>
        \n<\/span><\/span><\/span><\/span><\/span><\/span>Society of Nuclear Medicine and Molecular Imaging 2019 Annual Meeting<\/span>\u00a0(Anaheim, USA) June\u00a022-25, 2019<\/span><\/span><\/span><\/li>\n
      3. Sho Kaide, Hiroyuki Watanabe, Yoichi Shimizu, Shimpei Iikuni, Hideo Saji, Masahiro Ono<\/span><\/span><\/span><\/span><\/span>
        \nDevelopment of PET\/SPECT Imaging Probes Based on Benzimidazopyridine Scaffold for Detection of Tau Pathology in Alzheimer’s Disease<\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span>
        \n<\/span><\/span><\/span><\/span>The 11th Seoul-Kyoto-Osaka Joint Symposium on Pharmaceutical Sciences for Young Scientists<\/span><\/span><\/span> (Kyoto, Japan) June\u00a011-12, 2019<\/span><\/span><\/span><\/li>\n
      4. Hiroyuki Watanabe, Sho Kaide, Yuta Tarumizu, Yoichi Shimizu, Simpei Iikuni, Masahiro Ono<\/span><\/span><\/span><\/span><\/span><\/span>
        \nSynthesis and evaluation of 18<\/sup><\/span><\/span>F-labeled benzimidazopyridine derivatives as novel PET tracers for tau imaging<\/span>
        \n<\/span><\/span><\/span><\/span><\/span><\/span>The 23rd International Symposium on Radiopharmaceutical Sciences (Beijing, China) May\u00a026-31, 2019<\/span><\/span><\/span><\/li>\n
      5. \u5ca1\u7530 \u7950\u54c9,\u00a0<\/span>\u98ef\u570b \u614e\u5e73,\u00a0<\/span>\u6e21\u908a \u88d5\u4e4b,\u00a0<\/span>\u5fd7\u6c34 \u967d\u4e00,\u00a0<\/span>\u5c0f\u91ce \u6b63\u535a<\/span>
        \n<\/span><\/span><\/span><\/span>\u70ad\u9178\u8131\u6c34\u9175\u7d20IX\u30a4\u30e1\u30fc\u30b8\u30f3\u30b0\u30d7\u30ed\u30fc\u30d6\u306e\u958b\u767a\u3092\u76ee\u7684\u3068\u3057\u305f111<\/sup><\/span><\/span><\/span>In\u6a19\u8b58\u30a4\u30df\u30c0\u30be\u30c1\u30a2\u30b8\u30a2\u30be\u30fc\u30eb\u8a98\u5c0e\u4f53\u306e\u5408\u6210\u3068\u8a55\u4fa1<\/span><\/span><\/span><\/span><\/span><\/span>
        \n\u7b2c3\u56de\u65e5\u672c\u6838\u533b\u5b66\u4f1a\u5206\u79d1\u4f1a \u653e\u5c04\u6027\u85ac\u54c1\u79d1\u5b66\u7814\u7a76\u4f1a\/<\/span>\u7b2c<\/span>19<\/span>\u56de\u653e\u5c04\u6027\u533b\u85ac\u54c1\u30fb\u753b\u50cf\u8a3a\u65ad\u85ac\u7814\u7a76\u4f1a<\/span>\uff08\u5ca1\u5c71\uff09<\/span>2019\u5e7411\u670830\u65e5<\/span><\/li>\n
      6. \u5ddd\u91ce \u8056\u5fd7\u6717, \u6e21\u908a \u88d5\u4e4b, \u5fd7\u6c34 \u967d\u4e00, \u98ef\u570b \u614e\u5e73, \u5c0f\u91ce \u6b63\u535a<\/span>
        \n<\/span><\/span><\/span><\/span>\u81b5\u5cf6\u30a2\u30df\u30ea\u30f3\u306e\u751f\u4f53\u30a4\u30e1\u30fc\u30b8\u30f3\u30b0\u3092\u76ee\u7684\u3068\u3057\u305fPET\u30d7\u30ed\u30fc\u30d6\u306e\u958b\u767a<\/span><\/span><\/span><\/span><\/span><\/span>
        \n\u7b2c3\u56de\u65e5\u672c\u6838\u533b\u5b66\u4f1a\u5206\u79d1\u4f1a \u653e\u5c04\u6027\u85ac\u54c1\u79d1\u5b66\u7814\u7a76\u4f1a\/<\/span>\u7b2c<\/span>19<\/span>\u56de\u653e\u5c04\u6027\u533b\u85ac\u54c1\u30fb\u753b\u50cf\u8a3a\u65ad\u85ac\u7814\u7a76\u4f1a<\/span>\uff08\u5ca1\u5c71\uff09<\/span>2019\u5e7411\u670830\u65e5<\/span><\/li>\n
      7. \u5782\u6c34 \u52c7\u592a, \u6e21\u908a \u88d5\u4e4b, \u8c9d\u51fa \u7fd4, \u98ef\u570b \u614e\u5e73, \u5fd7\u6c34 \u967d\u4e00, \u5c0f\u91ce \u6b63\u535a<\/span><\/span><\/span>
        \n<\/span>\u65b0\u898fPET\u7528\u30bf\u30a6\u30a4\u30e1\u30fc\u30b8\u30f3\u30b0\u30d7\u30ed\u30fc\u30d6\u306e\u958b\u767a\u3092\u76ee\u7684\u3068\u3057\u305f18<\/sup>F\u6a19\u8b58\u30d9\u30f3\u30be\u30a4\u30df\u30c0\u30be\u30d4\u30ea\u30b8\u30f3\u8a98\u5c0e\u4f53\u306e\u5408\u6210\u3068\u8a55\u4fa1<\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span>
        \n\u7b2c59\u56de\u65e5\u672c\u6838\u533b\u5b66\u4f1a\u5b66\u8853\u7dcf\u4f1a\uff08\u611b\u5a9b) 2019\u5e7411\u67081\u65e5\u301c3\u65e5<\/span><\/span><\/span><\/span><\/li>\n
      8. \u6e21\u908a \u88d5\u4e4b, \u677e\u4e0b \u76f4\u6a39, \u5fd7\u6c34 \u967d\u4e00, \u98ef\u570b \u614e\u5e73, \u5c0f\u91ce \u6b63\u535a<\/span><\/span><\/span>
        \n<\/span>\u30aa\u30ec\u30ad\u30b7\u30f32\u53d7\u5bb9\u4f53\u3092\u6a19\u7684\u3068\u3057\u305f18<\/sup>F\u6a19\u8b58\u30b8\u30a2\u30ea\u30fc\u30eb\u30cb\u30b3\u30c1\u30f3\u30a2\u30df\u30c9\u8a98\u5c0e\u4f53\u306e\u5408\u6210\u3068\u8a55\u4fa1<\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span>
        \n\u7b2c59\u56de\u65e5\u672c\u6838\u533b\u5b66\u4f1a\u5b66\u8853\u7dcf\u4f1a\uff08\u611b\u5a9b) 2019\u5e7411\u67081\u65e5\u301c3\u65e5<\/span><\/span><\/span><\/span><\/li>\n
      9. \u8c9d\u51fa \u7fd4, \u6e21\u908a \u88d5\u4e4b, \u5fd7\u6c34 \u967d\u4e00, \u98ef\u570b \u614e\u5e73, \u4f0a\u6771 \u606d\u5b50, \u5c0f\u91ce \u6b63\u535a<\/span><\/span><\/span>
        \n<\/span>\u30d2\u30c8\u5256\u691c\u8133\u5207\u7247\u3092\u7528\u3044\u305fBIP-NMe2 <\/span><\/sub>\u306b\u95a2\u3059\u308b\u751f\u5316\u5b66\u7684\u8a55\u4fa1<\/span><\/span><\/span>
        \n\u7b2c59\u56de\u65e5\u672c\u6838\u533b\u5b66\u4f1a\u5b66\u8853\u7dcf\u4f1a\uff08\u611b\u5a9b) 2019\u5e7411\u67081\u65e5\u301c3\u65e5<\/span><\/span><\/span><\/span><\/li>\n
      10. \u98ef\u570b \u614e\u5e73<\/span><\/span><\/span>
        \n<\/span>Cancer radiotheranostics targeting carbonic anhydrase-IX with 111<\/sup>In- and 90<\/sup>Y-labeled ureidosulfonamide scaffold for SPECT imaging and radionuclide-based therapy (\u53d7\u8cde\u8b1b\u6f14)<\/span><\/span><\/span>
        \n\u7b2c59\u56de\u65e5\u672c\u6838\u533b\u5b66\u4f1a\u5b66\u8853\u7dcf\u4f1a\uff08\u611b\u5a9b) 2019\u5e7411\u67081\u65e5\u301c3\u65e5<\/span><\/span><\/span><\/span><\/li>\n
      11. \u98ef\u570b \u614e\u5e73, \u5c0f\u91ce \u6b63\u535a<\/span><\/span><\/span><\/span><\/span>
        \n<\/span><\/span><\/span><\/span>\u70ad\u9178\u8131\u6c34\u9175\u7d20IX\u30a4\u30e1\u30fc\u30b8\u30f3\u30b0\u30d7\u30ed\u30fc\u30d6\u3068\u3057\u3066\u306eIn-111\u6a19\u8b58\u30a4\u30df\u30c0\u30be\u30c1\u30a2\u30b8\u30a2\u30be\u30fc\u30eb\u30b9\u30eb\u30db\u30f3\u30a2\u30df\u30c9\u8a98\u5c0e\u4f53\u306e\u958b\u767a<\/span><\/span><\/span><\/span><\/span><\/span>
        \n\u7b2c78\u56de\u65e5\u672c\u764c\u5b66\u4f1a\u5b66\u8853\u7dcf\u4f1a\uff08\u4eac\u90fd\uff092019\u5e749\u670826\u301c28\u65e5<\/span><\/span><\/span><\/li>\n
      12. \u8c9d\u51fa \u7fd4, \u6e21\u908a \u88d5\u4e4b, \u5fd7\u6c34 \u967d\u4e00, \u8fb0\u5df3 \u60a0\u83ef, \u98ef\u570b \u614e\u5e73, \u5c0f\u91ce \u6b63\u535a<\/span><\/span><\/span><\/span><\/span>
        \n<\/span><\/span><\/span><\/span>\u30a2\u30eb\u30c4\u30cf\u30a4\u30de\u30fc\u75c5\u8133\u5185\u30bf\u30a6\u306ePET\u30a4\u30e1\u30fc\u30b8\u30f3\u30b0\u3092\u76ee\u7684\u3068\u3057\u305f18<\/sup>F\u6a19\u8b58\u30d9\u30f3\u30be\u30a4\u30df\u30c0\u30be\u30d4\u30ea\u30b8\u30f3\u8a98\u5c0e\u4f53\u306e\u958b\u767a<\/span><\/span><\/span><\/span><\/span><\/span>
        \n\u7b2c17\u56de\u6b21\u4e16\u4ee3\u3092\u62c5\u3046\u82e5\u624b\u306e\u305f\u3081\u306e\u30d5\u30a3\u30b8\u30ab\u30eb\u30fb\u30d5\u30a1\u30fc\u30de\u30d5\u30a9\u30fc\u30e9\u30e0\uff08\u6ecb\u8cc0\uff092019\u5e749\u67082\u65e5, 3\u65e5<\/span><\/span><\/span><\/li>\n
      13. \u5ddd\u91ce \u8056\u5fd7\u6717, \u6e21\u908a \u88d5\u4e4b, \u5fd7\u6c34 \u967d\u4e00, \u98ef\u570b \u614e\u5e73, \u5c0f\u91ce \u6b63\u535a<\/span>
        \n<\/span><\/span><\/span><\/span>\u7cd6\u5c3f\u75c5\u306b\u304a\u3051\u308b\u81b5\u81d3\u5185\u30a2\u30df\u30ea\u30f3\u3092\u6a19\u7684\u3068\u3057\u305f\u65b0\u898fPET\u30d7\u30ed\u30fc\u30d6\u306e\u958b\u767a<\/span><\/span><\/span><\/span><\/span><\/span>
        \n\u7b2c17\u56de\u6b21\u4e16\u4ee3\u3092\u62c5\u3046\u82e5\u624b\u306e\u305f\u3081\u306e\u30d5\u30a3\u30b8\u30ab\u30eb\u30fb\u30d5\u30a1\u30fc\u30de\u30d5\u30a9\u30fc\u30e9\u30e0\uff08\u6ecb\u8cc0\uff092019\u5e749\u67082\u65e5, 3\u65e5<\/span><\/span><\/span><\/li>\n
      14. \u98ef\u570b \u614e\u5e73, \u8c37\u6751 \u572d\u4e00, \u6e21\u908a \u88d5\u4e4b,\u00a0<\/span>\u5fd7\u6c34 \u967d\u4e00,\u00a0<\/span>\u5c0f\u91ce \u6b63\u535a<\/span><\/span><\/span><\/span>
        \n<\/span><\/span><\/span>\u70ad\u9178\u8131\u6c34\u9175\u7d20-IX\u9ad8\u767a\u73fe\u816b\u760d\u30a4\u30e1\u30fc\u30b8\u30f3\u30b0\u3092\u76ee\u7684\u3068\u3057\u305f99m<\/sup>Tc-\u30d2\u30c9\u30ed\u30ad\u30b5\u30e0\u30a2\u30df\u30c9\u932f\u4f53\u306e\u958b\u767a<\/span><\/span><\/span><\/span><\/span>
        \n\u7b2c14\u56de\u65e5\u672c\u5206\u5b50\u30a4\u30e1\u30fc\u30b8\u30f3\u30b0\u5b66\u4f1a\u7dcf\u4f1a\u30fb\u5b66\u8853\u96c6\u4f1a \uff08\u672d\u5e4c\uff092019\u5e745\u670823\u65e5, 24\u65e5<\/span><\/span><\/span><\/li>\n
      15. \u6e21\u908a \u88d5\u4e4b, \u4e09\u6728 \u7950\u5178, \u98ef\u570b \u614e\u5e73,\u00a0<\/span>\u5fd7\u6c34 \u967d\u4e00,\u00a0<\/span>\u5c0f\u91ce \u6b63\u535a<\/span><\/span><\/span><\/span>
        \n<\/span><\/span><\/span>\u81b5\u5cf6\u5185\u30a2\u30df\u30ea\u30f3\u3092\u6a19\u7684\u3068\u3057\u305f2\u5149\u5b50\u52b1\u8d77\u86cd\u5149\u30d7\u30ed\u30fc\u30d6\u306e\u958b\u767a<\/span><\/span><\/span>
        \n\u7b2c14\u56de\u65e5\u672c\u5206\u5b50\u30a4\u30e1\u30fc\u30b8\u30f3\u30b0\u5b66\u4f1a\u7dcf\u4f1a\u30fb\u5b66\u8853\u96c6\u4f1a \uff08\u672d\u5e4c\uff092019\u5e745\u670823\u65e5, 24\u65e5<\/span><\/span><\/span><\/li>\n
      16. \u5ca1\u7530 \u7950\u54c9,\u00a0<\/span>\u98ef\u570b \u614e\u5e73,\u00a0<\/span>\u6e21\u908a \u88d5\u4e4b,\u00a0<\/span>\u5fd7\u6c34 \u967d\u4e00,\u00a0<\/span>\u963f\u90e8 \u52d9,\u00a0<\/span>\u4f50\u6cbb \u82f1\u90ce,\u00a0<\/span>\u5c0f\u91ce \u6b63\u535a<\/span><\/span><\/span><\/span>
        \n\u70ad\u9178\u8131\u6c34\u9175\u7d20IX<\/span>\u30a4\u30e1\u30fc\u30b8\u30f3\u30b0\u3092\u76ee\u7684\u3068\u3057\u305f\u65b0\u898f111<\/span><\/sup>In<\/span>\u6a19\u8b58\u30a4\u30df\u30c0\u30be\u30c1\u30a2\u30b8\u30a2\u30be\u30fc\u30eb\u8a98\u5c0e\u4f53\u306e\u5408\u6210\u3068\u8a55\u4fa1<\/span><\/span><\/span><\/span>
        \n\u65e5\u672c\u85ac\u5b66\u4f1a \u7b2c139\u5e74\u4f1a (\u5343\u8449) 2019\u5e743\u670821\u65e5\u301c23\u65e5<\/span><\/span><\/span><\/li>\n
      17. \u677f\u57a3 \u98a8\u592a,\u00a0<\/span>\u6e21\u908a \u88d5\u4e4b,\u00a0<\/span>\u5fd7\u6c34 \u967d\u4e00,\u00a0<\/span>\u98ef\u570b \u614e\u5e73,\u00a0<\/span>\u5c0f\u91ce \u6b63\u535a<\/span><\/span><\/span><\/span>
        \n\u30bf\u30f3\u30d1\u30af\u8cea\u306e\u30c1\u30aa\u30fc\u30eb\u57fa\u3092\u4ecb\u3057\u305f\u86cd\u5149\u30fbRI<\/span>\u30c7\u30e5\u30a2\u30eb\u30e9\u30d9\u30eb\u5316\u5264\u3068\u3057\u3066\u306e\u653e\u5c04\u6027\u30e8\u30a6\u7d20\u6a19\u8b58BODIPY<\/span>\u8a98\u5c0e\u4f53\u306e\u5408\u6210\u3068\u8a55\u4fa1<\/span><\/span><\/span><\/span>
        \n\u65e5\u672c\u85ac\u5b66\u4f1a \u7b2c139\u5e74\u4f1a (\u5343\u8449) 2019\u5e743\u670821\u65e5\u301c23\u65e5<\/span><\/span><\/span><\/li>\n
      18. \u5782\u6c34 \u52c7\u592a, <\/span>\u6e21\u908a \u88d5\u4e4b,\u00a0<\/span>\u8c9d\u51fa \u7fd4,\u00a0<\/span>\u98ef\u570b \u614e\u5e73,\u00a0<\/span>\u5fd7\u6c34 \u967d\u4e00,\u00a0<\/span>\u5c0f\u91ce \u6b63\u535a<\/span><\/span><\/span><\/span>
        \n\u30a2\u30eb\u30c4\u30cf\u30a4\u30de\u30fc\u75c5\u8133\u5185\u30bf\u30a6\u306ePET<\/span>\u30a4\u30e1\u30fc\u30b8\u30f3\u30b0\u3092\u76ee\u7684\u3068\u3057\u305f18<\/span><\/sup>F<\/span>\u6a19\u8b58\u30d9\u30f3\u30be\u30a4\u30df\u30c0\u30be\u30d4\u30ea\u30b8\u30f3\u8a98\u5c0e\u4f53\u306e\u69cb\u9020\u6d3b\u6027\u52d5\u614b\u76f8\u95a2<\/span><\/span><\/span><\/span>
        \n\u65e5\u672c\u85ac\u5b66\u4f1a \u7b2c139\u5e74\u4f1a (\u5343\u8449) 2019\u5e743\u670821\u65e5\u301c23\u65e5<\/span><\/span><\/span><\/li>\n<\/ol>\n

        \u30da\u30fc\u30b8\u306e\u5148\u982d\u3078\u623b\u308b<\/a><\/p>\n

        \n","protected":false},"excerpt":{"rendered":"

        2019 (\u8ad6\u6587) Watanabe H, Matsushita N, Shimizu Y, Iikuni S, Nakamoto Y, Togashi K, Ono M. Synthesis and character […]<\/p>\n","protected":false},"author":14,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_crdt_document":"","footnotes":""},"class_list":["post-2985","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/www.pharm.kyoto-u.ac.jp\/byotai\/wp-json\/wp\/v2\/pages\/2985","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.pharm.kyoto-u.ac.jp\/byotai\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.pharm.kyoto-u.ac.jp\/byotai\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.pharm.kyoto-u.ac.jp\/byotai\/wp-json\/wp\/v2\/users\/14"}],"replies":[{"embeddable":true,"href":"https:\/\/www.pharm.kyoto-u.ac.jp\/byotai\/wp-json\/wp\/v2\/comments?post=2985"}],"version-history":[{"count":2,"href":"https:\/\/www.pharm.kyoto-u.ac.jp\/byotai\/wp-json\/wp\/v2\/pages\/2985\/revisions"}],"predecessor-version":[{"id":3209,"href":"https:\/\/www.pharm.kyoto-u.ac.jp\/byotai\/wp-json\/wp\/v2\/pages\/2985\/revisions\/3209"}],"wp:attachment":[{"href":"https:\/\/www.pharm.kyoto-u.ac.jp\/byotai\/wp-json\/wp\/v2\/media?parent=2985"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}